- Histologically or cytologically confirmed non-small cell lung cancer that is beyond
surgical cure or that is metastatic (Stage IIIB or IV according to AJCC).
- Patients must have measurable disease according to the RECIST criteria.
- Prior treatment with chemotherapy; patients may have received prior radiotherapy.
- Patients with suspected or known CNS metastases.